Investigating the dual nature of endothelin-1: Ischemia or direct arrhythmogenic effect?

Tamás Szabó, L. Gellér, B. Merkely, L. Selmeci, A. Juhász-Nagy, Francis Solti

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Endothelin-1 (ET-1) is a potent vasoconstrictor peptide, which may also elicit severe ventricular arrhythmias. The aims of our study were to compare the effects of total left anterior descending coronary artery (LAD) occlusion to intracoronary (ic.) ET-1 administration and to investigate the pathomechanism of ET-1 induced arrhythmias in 3 groups of anesthetized, open- chest mongrel dogs. In group A (n=10) a total LAD occlusion was carried out for 30 min, followed by a 60 min reperfusion period. In groups B and C ET-1 was administered into LAD for 30 min at a rate of 30 pmol/min (n=6) and 60 pmol/min (n=8). Epi- and endocardial monophasic action potential (MAP) recordings were performed to detect electrophysiologic changes and ischemia. Blood samples for lactate measurements were collected from the coronary sinus (CS) and from the femoral artery. Infrared imaging was applied to follow epimyocardial heat emission changes. At the end of the ET-1 infusion period coronary blood flow (CBF) was reduced significantly in groups B and C (ΔCBF(30MIN) B: 21±2%, p90) and left ventricular epicardial (LV(EPI)) upstroke velocity decreased significantly in group A in the occlusion period. ET-1 infusion significantly increased LV(EPI) MAPD90 in group B and both MAPD90-s in group C. In conclusion, ischemic MAP and CS lactate changes were observed only in group A. Although ET-1 reduced CBF significantly in groups B and C, neither MAP nor lactate indicated ischemic alterations. ET-1 induced major ventricular arrhythmias appeared before signs of myocardial ischemia developed, though reduced CBF presumably contributed to sustaining the arrhythmias.

Original languageEnglish
Pages (from-to)2527-2541
Number of pages15
JournalLife Sciences
Volume66
Issue number26
Publication statusPublished - May 19 2000

Fingerprint

Endothelin-1
Ischemia
Blood
Cardiac Arrhythmias
Action Potentials
Lactic Acid
Coronary Sinus
Infrared imaging
Vasoconstrictor Agents
Femoral Artery
Reperfusion
Myocardial Ischemia
Coronary Vessels
Thorax
Hot Temperature
Dogs
Peptides

Keywords

  • Cardiothermography
  • Endothelin-1
  • Ischemia
  • Monophasic action potential
  • Ventricular tachycardia

ASJC Scopus subject areas

  • Pharmacology

Cite this

Investigating the dual nature of endothelin-1 : Ischemia or direct arrhythmogenic effect? / Szabó, Tamás; Gellér, L.; Merkely, B.; Selmeci, L.; Juhász-Nagy, A.; Solti, Francis.

In: Life Sciences, Vol. 66, No. 26, 19.05.2000, p. 2527-2541.

Research output: Contribution to journalArticle

@article{917b1294a3bb46189b601b944d37ee64,
title = "Investigating the dual nature of endothelin-1: Ischemia or direct arrhythmogenic effect?",
abstract = "Endothelin-1 (ET-1) is a potent vasoconstrictor peptide, which may also elicit severe ventricular arrhythmias. The aims of our study were to compare the effects of total left anterior descending coronary artery (LAD) occlusion to intracoronary (ic.) ET-1 administration and to investigate the pathomechanism of ET-1 induced arrhythmias in 3 groups of anesthetized, open- chest mongrel dogs. In group A (n=10) a total LAD occlusion was carried out for 30 min, followed by a 60 min reperfusion period. In groups B and C ET-1 was administered into LAD for 30 min at a rate of 30 pmol/min (n=6) and 60 pmol/min (n=8). Epi- and endocardial monophasic action potential (MAP) recordings were performed to detect electrophysiologic changes and ischemia. Blood samples for lactate measurements were collected from the coronary sinus (CS) and from the femoral artery. Infrared imaging was applied to follow epimyocardial heat emission changes. At the end of the ET-1 infusion period coronary blood flow (CBF) was reduced significantly in groups B and C (ΔCBF(30MIN) B: 21±2{\%}, p90) and left ventricular epicardial (LV(EPI)) upstroke velocity decreased significantly in group A in the occlusion period. ET-1 infusion significantly increased LV(EPI) MAPD90 in group B and both MAPD90-s in group C. In conclusion, ischemic MAP and CS lactate changes were observed only in group A. Although ET-1 reduced CBF significantly in groups B and C, neither MAP nor lactate indicated ischemic alterations. ET-1 induced major ventricular arrhythmias appeared before signs of myocardial ischemia developed, though reduced CBF presumably contributed to sustaining the arrhythmias.",
keywords = "Cardiothermography, Endothelin-1, Ischemia, Monophasic action potential, Ventricular tachycardia",
author = "Tam{\'a}s Szab{\'o} and L. Gell{\'e}r and B. Merkely and L. Selmeci and A. Juh{\'a}sz-Nagy and Francis Solti",
year = "2000",
month = "5",
day = "19",
language = "English",
volume = "66",
pages = "2527--2541",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "26",

}

TY - JOUR

T1 - Investigating the dual nature of endothelin-1

T2 - Ischemia or direct arrhythmogenic effect?

AU - Szabó, Tamás

AU - Gellér, L.

AU - Merkely, B.

AU - Selmeci, L.

AU - Juhász-Nagy, A.

AU - Solti, Francis

PY - 2000/5/19

Y1 - 2000/5/19

N2 - Endothelin-1 (ET-1) is a potent vasoconstrictor peptide, which may also elicit severe ventricular arrhythmias. The aims of our study were to compare the effects of total left anterior descending coronary artery (LAD) occlusion to intracoronary (ic.) ET-1 administration and to investigate the pathomechanism of ET-1 induced arrhythmias in 3 groups of anesthetized, open- chest mongrel dogs. In group A (n=10) a total LAD occlusion was carried out for 30 min, followed by a 60 min reperfusion period. In groups B and C ET-1 was administered into LAD for 30 min at a rate of 30 pmol/min (n=6) and 60 pmol/min (n=8). Epi- and endocardial monophasic action potential (MAP) recordings were performed to detect electrophysiologic changes and ischemia. Blood samples for lactate measurements were collected from the coronary sinus (CS) and from the femoral artery. Infrared imaging was applied to follow epimyocardial heat emission changes. At the end of the ET-1 infusion period coronary blood flow (CBF) was reduced significantly in groups B and C (ΔCBF(30MIN) B: 21±2%, p90) and left ventricular epicardial (LV(EPI)) upstroke velocity decreased significantly in group A in the occlusion period. ET-1 infusion significantly increased LV(EPI) MAPD90 in group B and both MAPD90-s in group C. In conclusion, ischemic MAP and CS lactate changes were observed only in group A. Although ET-1 reduced CBF significantly in groups B and C, neither MAP nor lactate indicated ischemic alterations. ET-1 induced major ventricular arrhythmias appeared before signs of myocardial ischemia developed, though reduced CBF presumably contributed to sustaining the arrhythmias.

AB - Endothelin-1 (ET-1) is a potent vasoconstrictor peptide, which may also elicit severe ventricular arrhythmias. The aims of our study were to compare the effects of total left anterior descending coronary artery (LAD) occlusion to intracoronary (ic.) ET-1 administration and to investigate the pathomechanism of ET-1 induced arrhythmias in 3 groups of anesthetized, open- chest mongrel dogs. In group A (n=10) a total LAD occlusion was carried out for 30 min, followed by a 60 min reperfusion period. In groups B and C ET-1 was administered into LAD for 30 min at a rate of 30 pmol/min (n=6) and 60 pmol/min (n=8). Epi- and endocardial monophasic action potential (MAP) recordings were performed to detect electrophysiologic changes and ischemia. Blood samples for lactate measurements were collected from the coronary sinus (CS) and from the femoral artery. Infrared imaging was applied to follow epimyocardial heat emission changes. At the end of the ET-1 infusion period coronary blood flow (CBF) was reduced significantly in groups B and C (ΔCBF(30MIN) B: 21±2%, p90) and left ventricular epicardial (LV(EPI)) upstroke velocity decreased significantly in group A in the occlusion period. ET-1 infusion significantly increased LV(EPI) MAPD90 in group B and both MAPD90-s in group C. In conclusion, ischemic MAP and CS lactate changes were observed only in group A. Although ET-1 reduced CBF significantly in groups B and C, neither MAP nor lactate indicated ischemic alterations. ET-1 induced major ventricular arrhythmias appeared before signs of myocardial ischemia developed, though reduced CBF presumably contributed to sustaining the arrhythmias.

KW - Cardiothermography

KW - Endothelin-1

KW - Ischemia

KW - Monophasic action potential

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=0034685928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034685928&partnerID=8YFLogxK

M3 - Article

C2 - 10883731

AN - SCOPUS:0034685928

VL - 66

SP - 2527

EP - 2541

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 26

ER -